These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24768010)

  • 1. Distinct metabolic characteristics and risk of stone recurrence in patients with multiple stones at the first-time presentation.
    Kang HW; Seo SP; Kwon WA; Woo SH; Kim WT; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Urology; 2014 Aug; 84(2):274-8. PubMed ID: 24768010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia is associated with increased risk for stone recurrence in patients with urolithiasis.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Urology; 2014 Oct; 84(4):766-71. PubMed ID: 25106943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Characteristics and Risks Associated with Stone Recurrence in Korean Young Adult Stone Patients.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Kim WJ; Lee SC
    J Endourol; 2017 Aug; 31(8):806-811. PubMed ID: 28537440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing composition of staghorn calculi.
    Viprakasit DP; Sawyer MD; Herrell SD; Miller NL
    J Urol; 2011 Dec; 186(6):2285-90. PubMed ID: 22014820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm followup study.
    Lee YH; Huang WC; Tsai JY; Huang JK
    J Urol; 1999 May; 161(5):1453-7. PubMed ID: 10210371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric urinary stone disease--does age matter?
    Kalorin CM; Zabinski A; Okpareke I; White M; Kogan BA
    J Urol; 2009 May; 181(5):2267-71; discussion 2271. PubMed ID: 19296968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting for stone in augmented bladders-what is the risk of recurrence and is it impacted by treatment modality?
    Szymanski KM; Misseri R; Whittam B; Amstutz S; Kaefer M; Rink RC; Cain MP
    J Urol; 2014 May; 191(5):1375-80. PubMed ID: 24316089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stone growth patterns and risk for surgery among children presenting with hypercalciuria, hypocitraturia and cystinuria as underlying metabolic causes of urolithiasis.
    Zu'bi F; Sidler M; Harvey E; Lopes RI; Hojjat A; Naoum N; Pokarowski M; Lorenzo AJ; Farhat WA; Papanikolaou F; Dos Santos J
    J Pediatr Urol; 2017 Aug; 13(4):357.e1-357.e7. PubMed ID: 28865885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
    Robinson MR; Leitao VA; Haleblian GE; Scales CD; Chandrashekar A; Pierre SA; Preminger GM
    J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
    DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
    Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary citrate in kidney stone disease.
    Usui Y; Matsuzaki S; Matsushita K; Shima M
    Tokai J Exp Clin Med; 2003 Jul; 28(2):65-70. PubMed ID: 14714831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of metabolic syndrome on long-term outcomes of percutaneous nephrolithotomy (PCNL).
    Akman T; Binbay M; Erbin A; Tepeler A; Sari E; Kucuktopcu O; Ozgor F; Muslumanoglu A
    BJU Int; 2012 Dec; 110(11 Pt C):E1079-83. PubMed ID: 23046168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of hypocitraturia in kidney stone patients.
    Matsushita K; Tanikawa K; Masuda A; Matsuzaki S
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1253-7. PubMed ID: 8139138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone.
    Trinchieri A; Ostini F; Nespoli R; Rovera F; Montanari E; Zanetti G
    J Urol; 1999 Jul; 162(1):27-30. PubMed ID: 10379732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric urolithiasis--evaluation of risk factors in 95 children.
    Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
    Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys.
    Raj GV; Auge BK; Assimos D; Preminger GM
    J Endourol; 2004 Mar; 18(2):157-61. PubMed ID: 15072623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.